On Friday, Carisma Therapeutics Inc (NASDAQ: CARM) trading session started at the price of On Friday, that was 4.14% up from the session before settling in for the closing price of $0.44. A 52-week range for CARM has been $0.38 – $3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 25.00%. When this article was written, the company’s average yearly earnings per share was at 53.13%. With a float of $21.84 million, this company’s outstanding shares have now reached $41.75 million.
Let’s determine the extent of company efficiency that accounts for 107 employees. In terms of profitability, gross margin is 80.11%, operating margin of -329.46%, and the pretax margin is -315.75%.
Carisma Therapeutics Inc (CARM) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Carisma Therapeutics Inc stocks. The insider ownership of Carisma Therapeutics Inc is 47.70%, while institutional ownership is 11.18%.
Carisma Therapeutics Inc (CARM) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.13% per share during the next fiscal year.
Carisma Therapeutics Inc (NASDAQ: CARM) Trading Performance Indicators
You can see what Carisma Therapeutics Inc (CARM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Carisma Therapeutics Inc (CARM)
Looking closely at Carisma Therapeutics Inc (NASDAQ: CARM), its last 5-days average volume was 0.39 million, which is a jump from its year-to-date volume of 0.34 million. As of the previous 9 days, the stock’s Stochastic %D was 41.76%. Additionally, its Average True Range was 0.06.
During the past 100 days, Carisma Therapeutics Inc’s (CARM) raw stochastic average was set at 9.13%, which indicates a significant decrease from 18.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 148.12% in the past 14 days, which was higher than the 82.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8117, while its 200-day Moving Average is $1.2070. However, in the short run, Carisma Therapeutics Inc’s stock first resistance to watch stands at $0.5002. Second resistance stands at $0.5400. The third major resistance level sits at $0.5660. If the price goes on to break the first support level at $0.4344, it is likely to go to the next support level at $0.4084. Should the price break the second support level, the third support level stands at $0.3686.
Carisma Therapeutics Inc (NASDAQ: CARM) Key Stats
There are 41,750K outstanding shares of the company, which has a market capitalization of 20.02 million. As of now, sales total 14,920 K while income totals -86,880 K. Its latest quarter income was 3,390 K while its last quarter net income were -12,700 K.
